Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study-Reference-Cited by-同舟云学术

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study

Published:2022-03-21 Issue:7 Volume:117 Page:1972-1981
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Gomes Tara¹²³⁴^ORCID,McCormack Daniel³,Bozinoff Nikki⁵⁶,Tadrous Mina²³⁷,Antoniou Tony¹³⁶⁸,Munro Charlotte⁹,Campbell Tonya¹,Paterson J. Michael³⁴¹⁰,Mamdani Muhammad¹²³⁴,Sproule Beth²⁵¹¹

Affiliation:

1. Li Ka Shing Knowledge Institute of St. Michael's Hospital Toronto Ontario Canada

2. Leslie Dan Faculty of Pharmacy University of Toronto Toronto Ontario Canada

3. ICES Toronto Ontario Canada

4. Institute for Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada

5. Centre for Addiction and Mental Health Toronto Ontario Canada

6. Department of Family and Community Medicine University of Toronto Toronto Ontario Canada

7. Women's College Hospital Toronto Ontario Canada

8. Department of Family and Community Medicine, St. Michael's Hospital Toronto Ontario Canada

9. Ontario Drug Policy Research Network Lived Experience Advisory Group St Michael's Hospital Toronto Ontario Canada

10. Department of Family Medicine McMaster University Hamilton Ontario Canada

11. Department of Psychiatry University of Toronto Toronto Ontario Canada

Funder

Ministry of Health, British Columbia

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15862

Reference38 articles.

1. Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study

2. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019

3. Government of CanadaOpioid‐ and Stimulant‐related Harms in Canada 2021 [updated March 24 2021]. Available at:https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/. Accessed 28 July 2021.

4. Understanding the Implications of a Shifting Opioid Landscape in Ontario

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of retention in heroin-assisted treatment in Denmark 2010–2018 – A record-linkage study;Journal of Substance Use and Addiction Treatment;2024-10

2. Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type;Addiction;2024-09-07

3. Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional study;Drug and Alcohol Dependence Reports;2024-09

4. The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review;Journal of Addiction Medicine;2024-08-12

5. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis;Harm Reduction Journal;2024-05-16